Access cutting-edge thyroid cancer treatment through this clinical trial at a research site in New York. Study-provided care at no cost to qualified participants.
Access thyroid cancer specialists in New York at no cost
This study follows strict safety protocols and ethical guidelines
All study-related thyroid cancer treatment provided free
This research is being done to evaluate the safety and efficacy of neoadjuvant lenvatinib on surgical outcomes of patients with invasive extrathyroidal differentiated thyroid cancer (DTC). This research study involves a study drug called lenvatinib
Sponsor: Massachusetts Eye and Ear Infirmary
Check if you qualify for this thyroid cancer clinical trial in New York, NY
If you're searching for thyroid cancer treatment options in New York, NY, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our New York research site is actively enrolling participants for this clinical trial. You'll receive care from experienced thyroid cancer specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.